Less than 250,000 shares traded. Looks like we're buying and selling to ourselves. The company profile is non-existent despite the SA article. After all these years, roughly from 2009 until now, the situation to outsiders has not changed. We have a different perspective, but the rest of the world is still waiting for:

Non-toxic funding
Scientific breakthrough with a moat
Spinoff of AE, now NGIO
Uplisting to NASDAQ

The share price won't move upward until one or more of these are accomplished. I guess awarding the S-1 would be a good, reasonable start. And from my perspective, the others are still within the realm of possibility.

Anticipation! We need a new bottle of ketchup. LOL